The mortality rates in registries of patients with STEMI are highly affected by inclusion criteria and population characteristics. Issue 5 (16th July 2021)

• Record Type: Journal Article
• Authors: Martins, Elie; Magne, Julien; Pradel, Valérie; Faugeras, Gilles; Bosle, Sebastien; Cailloce, Dominique; Darodes, Nicole; Fleurant, Eric; Karam, Henri; Petitcolin, Pierre Bernard; Pages, Pierre A.; Rousselle, Virginie; Virot, Patrice; Aboyans, Victor
• Is Part Of: Acta cardiologica. Volume 76:Issue 5(2021)
• Page Start: 504
• Page End: 512
• Publication Date: 2021-07-16
• Subjects: ST-segment elevation myocardial infarction -- mortality -- registry -- methodology; Cardiology -- Periodicals; Cardiology; Cardiologie -- Périodiques; Cardiology; Cardiologie; Periodicals; Periodicals; 616.12005
• DOI: 10.1080/00015385.2020.1848970
• Languages: English
• ISSNs: 0001-5385

Abstract

Abstract: Background: Different mortality rates are reported in registries of patients with ST-segment elevation myocardial infarction (STEMI), but comparisons between registries are challenging. Aims: To determine whether the higher mortality rate in our regional French registry (SCALIM) is related to different inclusion criteria and demographic characteristics. Methods: The SCALIM registry included all patients with STEMI within the first 24 h in the region of Limousin, France (06/2011–01/2015). To compare mortality rates with other contemporary registries in France and European neighbouring countries, the others' inclusion criteria were applied to the SCALIM registry. Results: Among 1501 patients included, in-hospital and 1-month mortality were 8.2% and 8.8% respectively, significantly higher than many other registries. The use of inclusion criteria from EMUST (France), MINAP (UK) or LOMBARDIMA (Italy) markedly decreased the number of enrolled patients by 64%, 36%, and 21%, respectively. When those inclusion criteria were applied to the SCALIM registry, difference in in-hospital and 1-month mortality rates between other registries and ours remained significant. In the multivariate analysis, age, initial acute pulmonary oedema (Killip class ≥2), complication occurring before percutaneous coronary intervention, absence of transfer to an interventional cardiology centre for primary angioplasty and lack of reperfusion therapy within 12 h were associated with higher risk of 1-month mortality (all p < 0.05). Age (65 versus 63.3 years, p < 0.001) was higher and reperfusion rate (84.2 versus 74.7%, p < 0.001) was significantly lower in SCALIM than FAST-MI, the national French registry on STEMI patients. Interestingly, the 3% of patients included in SCALIM who would be excluded from FAST-MI registry had 91% mortality at one month. Conclusion: Higher mortality rate in our regional SCALIM registry is in part due to differences in inclusion criteria and demographic data. Consensus should be made to harmonise inclusion criteria in STEMI registries for the sake of comparability.